Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- Check3 days agoChange DetectedAdded a new 2024 publication citation about long-term safety of gantenerumab (Marguerite RoAD) to the Publications section. Updated the revision tag from v3.6.0 to v3.6.2.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now includes a recruitment status update and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a Revision: v3.6.0 note; the previous text items 'Intervention / Treatment' and 'Revision: v3.5.5' were removed.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This represents a minor update to the page version and does not change any study information.SummaryDifference0.0%

- Check32 days agoChange DetectedNo textual changes were detected for the Study Details page; the content remains unchanged. This indicates the page’s information and structure are the same as before.SummaryDifference0.0%

- Check39 days agoChange DetectedNo textual additions or deletions were provided for this study page, indicating no reported updates in the given dataset.SummaryDifference0.0%

- Check46 days agoChange DetectedThe site version was updated from v3.5.3 to v3.5.4, indicating deployment of updates to the ClinicalTrials.gov interface. The change does not alter the study details or displayed content.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.